Which route for misoprostol best cuts bleeding in C-Sections?
NCT ID NCT07728084
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial tests whether giving misoprostol into the uterus or through the rectum better reduces blood loss during and after planned cesarean delivery. One hundred forty low-risk pregnant women will receive the drug by one of these two routes. The goal is to find the most effective way to prevent postpartum hemorrhage, a leading cause of maternal complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- misoprostol tablets given either rectally or into the uterus
- What this could lead to
- If one method works better, it could lead to a safer, simpler way to prevent dangerous bleeding after cesarean delivery.
- What could go wrong
- This is a small, single-center trial, so results may not apply to all women. Both routes can cause side effects like shivering or fever.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE， CESAREAN SECTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University
Cairo, Cairo Governorate, 12111, Egypt